ArticleESMO gastrointestinal oncology2026

UCCL-IKF-AIO-STO-0124 NeoART-an international phase Ib/II platform trial investigating trastuzumab deruxtecan (T-DXd) combined with neoadjuvant chemotherapy for HER2-positive, resectable esophagogastric adenocarcinoma (EGA).

G Stocker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.